Videos

Paul L. Nguyen, MD, discusses the optimal duration of androgen deprivation therapy in patients with high-risk prostate cancer.

Dr. Nguyen on the Optimal Duration of ADT in High-Risk Prostate Cancer

Atish D. Choudhury, MD, PhD, discusses the goal of treating patients with nonmetastatic castration-resistant prostate cancer.

Dr. Choudhury on Treatment Goals in Nonmetastatic CRPC

Atish D. Choudhury, MD, PhD, compares the safety profiles of antiandrogen agents in nonmetastatic castration-resistant prostate cancer.  



Dr. Choudhury on the Safety Profiles of Antiandrogens in Nonmetastatic CRPC 

Quoc-Dien Trinh, MD, discusses the challenges of re-establishing standard surgical procedures in patients with prostate cancer following the initial wave of the coronavirus disease 2019 pandemic. 



Dr. Trinh on Re-Establishing Standard Surgical Procedures in Prostate Cancer 

Quoc-Dien Trinh, MD, discusses the impact of the coronavirus disease 2019  pandemic on prostate cancer.

Dr. Trinh on the Impact of the COVID-19 Pandemic on Prostate Cancer

Atish D. Choudhury, MD, PhD, discusses the different states of nonmetastatic castration-resistant prostate cancer.








Dana Farber

Latest from Dana Farber

New content coming soon, please check back later.